Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model - Top-Institutions - MDSpire

Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model

  • By

  • Qian Liu

  • Huizhong Tan

  • Keke Tong

  • Ruhai Luo

  • Hanquan Li

  • Feng Qiu

  • Shiliang Wang

  • Le Xie

  • Xiuli Zhang

  • Dahua Wu

  • July 9, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

  • #2

    The Johns Hopkins Hospital
    The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

Original Source(s)

Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model

  • by Qian Liu, Huizhong Tan, Keke Tong, Ruhai Luo, Hanquan Li, Feng Qiu, Shiliang Wang, Le Xie, Xiuli Zhang, Dahua Wu

  • July 9, 2026

Related Content

Longitudinal changes in the ALPS index and its clinical correlates in patients with basal ganglia hemorrhage

The hidden dangers of cerebral venous sinus thrombosis: insights into maternal morbidity and mortality during pregnancy

Research progress on the effects of epidural electrical stimulation on lower extremity function in patients with spinal cord injury